1 / 51

Lung Nodules

Lung Nodules. Frans Naudé. Definition of Pulmonary nodule. Rounded opacity , moderately well defined < 3cm in diameter. Web p 97. General Approach to lung nodules. Position Is it a lung nodule? Skin tags, nipple shadows, bone lesions Distribution in the lung

homer
Download Presentation

Lung Nodules

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Lung Nodules Frans Naudé

  2. Definition of Pulmonary nodule • Rounded opacity , moderately well defined • < 3cm in diameter Web p 97

  3. General Approach to lung nodules Position • Is it a lung nodule? • Skin tags, nipple shadows, bone lesions • Distribution in the lung Number of Nodules ( SPN, Multiple) Compare with previous radiographs Interpreting CXR p102

  4. Web p185

  5. P84, Computed Tomography of the Lung, Verschakelen

  6. Lung nodules: Imaging Modalities • CXR • CT ( HRES) • PET/CT : F18-FDG

  7. Description of pulmonary nodule • Pattern of distribution (Relationship to fissures, pleura, secondary lobules) • Edge characteristics (sharp, poorly circumscribed, ground glass) • Morphology ( branching/ tree in bud) • Size: • Pulmonary nodule <3cm • Small nodule < 1cm Web p97 High resolution CT of the lung

  8. Large nodules 1-3cm(Easily seen on CXR)

  9. HRES CTAnatomy of pulmonary lobule

  10. Secondary pulmonary lobule interlobular septa centrilobular region lobular lung parenchyma Blue = Pulmonary veins Green = lymphatic's Yellow= bronchiolar branches Red = Arteries White = Connective tissue Computed Tomography of the lung p9

  11. Secondary pulmonary lobule Prof Naidich

  12. HRES CT • Interstitial nodules vs Air space nodules

  13. WEB-Algorithmic approach to nodules P120 High resolution CT lung ,Web - approach

  14. CT of the lung , p74

  15. CT of the lung , p72

  16. HRES CT High resolution CT lung ,Web – Algorithm 4

  17. Airspace nodules • = centrilobular distribution • = no pleural/septal nodules • Ground-glass opacification/ less dense than adjacent blood vessels

  18. Centrilobular nodules : Tree in Bud

  19. Tree – in - Bud • PT with TB • Indicative of endobronchial spread P83, Computed Tomography of the Lung,Verschakelen

  20. Infective bronchiolitis • Tree in Bud appearance • Bronchial wall thickening Computed Tomography of the Lung,Verschakelen

  21. HRES CTTree in bud absent High resolution CT lung ,Web - approach

  22. Centrilobular: Tree in bud absent

  23. Poorly defined hazy ground glass nodules • Respiratory bronchiolitis • Langercellhistiocytosis • Lymphocytic interstitial pneumonitis

  24. Interstitial nodules • = pleural/ septal predominance

  25. HRES CTPerilymphatic High resolution CT lung ,Web - approach

  26. Perilymphatic disease • Clustered nodules • Adjacent to fissures and pleural surfaces and along central vascular structures • DDX: Sarcoid, silicosis, CWP. • Rare: Amyloid ,LIP

  27. Sarcoidosis P83, Computed Tomography of the Lung,Verschakelen

  28. Silicosis Web p305

  29. Web p 306

  30. Coal workers pneumoconiosis Web p 306 Diffuse pattern more in favour of CWP or silicosis than sarcoidosis

  31. HRES CTRandom High resolution CT lung ,Web - approach

  32. Random nodules • Sharply define,+- feeding vessel DDX • Metastases: lung, breast, kidney, colon, melanoma, thyroid , pancreas • Infection: Milliary TB, septic emboli, fungal infection • Vasculitis • Langercellhistiocytosis

  33. Metastases • Random • Basilar predominance P82, Computed Tomography of the Lung,Verschakelen

  34. CT of the lung, p 75

  35. Perilymphatic vs. centrilobular TB Centrilobular changes : nodules, tree-in-bud, branching lines Sarcoidosis - Fissural and subpleural nodules

  36. Perilymphaticnodules. Nodules are immediately in contact with interlobular septa and the visceral pleura (B) Centrilobular nodules. Nodules are positioned 5 - 10 mm from costal and visceral pleural surfaces and interlobular septa.

  37. High resolution CT lung ,Web - approach

  38. References • High resolution CT of the lung, Web, Naidich • CT of the lung, Verschakelen, De Wever • Prof Naidich RSSA lecture • High-Resolution CT of the Lung: Patterns of Disease and Differential Diagnoses, RadiolClin N Am 43 (2005) 513 – 542 • Imaging of Interstitial Lung Disease, RadiolClin N Am 43 (2005) 589 – 599

  39. SPN Def: focal area of increased round /oval density in the lung parenchyma measuring less than 3cm, Cause : infection, malignancy , inflammation, vascular, congenital Risk : 30-40% malignant

  40. Radiographics 2000:20: 43

  41. Approach to SPN • Morphology: • - Size ( smaller more likely benign) • - margins and contours

  42. Internal characteristics • Homogeneous attenuation (55% benign, 20%malignant) • Pseudocavitation and air bronchograms: lymphoma or bronchioalveolar cancer • Benign cavitation : smooth ,thin walls (<4mm) • Malignant cavitation: thick irregular walls( >16mm) • Intranodular fat = hamartoma • Benign calcification : • post infection: central, diffuse solid, laminated , • hamartoma : popcorn like • Malignant calcification: diffuse,amorphous,punctate • Metastatic osteosarcoma: high attenuation nodule

  43. 25-39% malignant nodules classified as benign on radiological morphology assessment • growth rate assessment: doubling rate ( increase in diameter of >26%) for malignant nodules between 30-400 days • Clinical data: age, risk factors, previous malignancy

  44. Distribution of lung nodules • Cancer – basal predominance • Breast CA, Colon, Renal often metastasize to lung Interpreting CXR p100

  45. Size of lung nodules • Mayo clinic CT screening trial • ( in patients with no history of cancer) • <3mm = less than 0,2% malignant • <5mm = fewer than 1% malignant • 4-7mm = 0,9% malignant • 8-20mm = 18% malignant • >20mm = 50% malignant Radiology Nov 2005 p 397

  46. Follow-up National Lung Screening Trial • nodules smaller than 4mm • return for screening after 12 months, without interval scans or other work-up Radiology Nov 2005 p 397

More Related